Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination diuretics in acutely decompensated heart failure with acute kidney injury
RBR-2xjfkk8Not yet recruiting
- Sponsor
- UNESP Botucatu Medical School
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of furosemide, acetazolamide and hydrochlorothiazide in heart failure (HF) and acute kidney failure (AKF), sponsored by UNESP Botucatu Medical School. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
furosemideacetazolamidehydrochlorothiazide
03
Conditions
heart failure (HF)acute kidney failure (AKF)
Beyond the preview
Go deeper on RBR-2xjfkk8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2xjfkk8.